Loading
Archives of Stem Cell and Therapy
ISSN: 2767-343X
Volume 3, Issue 1, p1-35
Articles published in this issue are Open Access and licensed under Creative Commons Attribution License (CC BY NC) where the readers can reuse, download, distribute the article in whole or part by mentioning proper credits to the authors.
Deregulation of Slug/Snail2 and TGF-β crosstalk in airway epithelial stem/progenitor cells: A key link between COPD and lung cancer?
This commentary focuses on two recent publications showing deregulation of the transcription factor Slug/Snail2 and TGF-β function in primary bronchial basal/progenitor cells of patients with Chronic Obstructive Pulmonary Disease (COPD) and the impact on proliferation and the expression of genes involved in stem cell maintenance. We discuss the molecular mechanisms related to the exhaustion of airway basal stem/progenitor cells in tobacco smoke-induced COPD, as well as putative links between COPD and lung cancer at the molecular level.
Arch Stem Cell Ther, 2022, Volume 3, Issue 1, p1-5 | DOI: 10.46439/stemcell.3.011
Nemo-like kinase as a potential target for treatment of Diamond Blackfan Anemia
Diamond Blackfan Anemia (DBA) is a congenital bone marrow failure syndrome characterized by hypoproliferative anemia, in which the major defect is ineffective erythropoiesis. Over 70% of patients with DBA have mutations in ribosomal protein subunits, although the precise molecular mechanisms contributing to the pathogenesis of DBA are not well understood.
Arch Stem Cell Ther, 2022, Volume 3, Issue 1, p6-10 | DOI: 10.46439/stemcell.3.012
The significance of triple-capsid-mutant AAV8 for treatment of Sanfilippo Syndrome Type B
Sanfilippo Syndrome Type-B remains an untreatable childhood neurodegenerative disease with great burden for both patient and caregiver. Very few clinical trials have been undertaken to treat the disease, and none of these have yet yielded clinically obtainable products for patients. Caused by a simple enzyme function deficiency, Sanfilippo Syndrome Type-B has been considered a great prospect for gene-therapy interventions.
Arch Stem Cell Ther, 2022, Volume 3, Issue 1, p11-17 | DOI: 10.46439/stemcell.3.013
Mesenchymal Stem Cells and PRP combined therapy promotes gastric leak closure following sleeve gastrectomy
Sleeve gastrectomy is the most common bariatric surgery worldwide. However, such a surgery caries risk of complications associated with morbidity and mortality. Gastric leak can occur and represents one of the most severe complications following sleeve gastrectomy. Since the two last decades, regenerative medicine has emerged, offering new strategies to face to sleeve gastrectomy complications.
Arch Stem Cell Ther, 2022, Volume 3, Issue 1, p18-22 | DOI: 10.46439/stemcell.3.014
Post-allogeneic stem cell transplant FLT3-targeted maintenance therapy: updates and considerations for clinical practice
Acute myeloid leukemia (AML) is characterized by multiple molecular and cytogenetic abnormalities, with increasing data to support clinical and prognostic implications to guide clinical decision making. One of the most well described mutations involves fms-like tyrosine kinase 3 (FLT3) that results in a constitutively active tyrosine kinase and is generally associated with poor prognosis involving shorter overall survival and higher rates of relapse.
Arch Stem Cell Ther, 2022, Volume 3, Issue 1, p23-27 | DOI: 10.46439/stemcell.3.015
Considering Taguchi method as a feature selection method in agent-based models of cancer disease: A mini-review
Cancer biology involves complex dynamics and interactions between cells and the tissue environment. Mathematical modeling and computer simulation can provide a powerful instrument for considering this complexity. Agent-based modeling is a particular discrete hybrid modeling method.
Arch Stem Cell Ther, 2022, Volume 3, Issue 1, p28-31 | DOI: 10.46439/stemcell.3.016
Can regulatory-driven process innovation open the door for cellular therapies in emerging markets?
Due to their impressive clinical success, CAR-T therapies are becoming a more mainstream treatment for patients with hematologic malignancies. In order to make this promising form of therapy accessible to patients in need worldwide, a robust scale-up of such a complex supply chain, that is also affordable worldwide, is essential. Already a challenging endeavor in most privileged countries, but a chimerical undertaking in the more logistically challenged regions and emerging markets across the globe.
Arch Stem Cell Ther, 2022, Volume 3, Issue 1, p32-35 | DOI: 10.46439/stemcell.3.017
Harnessing innovation for the future of breast cancer management
Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancerrelated mortality in women worldwide. Incidence rates continue to rise globally. Breast cancer encompasses a heterogeneous group of tumors with varying molecular features, clinical behaviors, and responses to therapy. While survival rates have improved, challenges persist such as invasive cancers, recurrent metastatic disease, and mortality among subgroups.
How to improve the regenerative potential of mesenchymal stem cells (MSCs) for the use in regenerative medicine?
Mesenchymal stem cells (MSCs) are widely used in regenerative medicine. They can be isolated from different adult tissues. However, the regenerative potential of MSCs obtained from various sources and from different age donors may significantly differ.
Role of the rapid delayed rectifier K+ current in human induced pluripotent stem cells derived cardiomyocytes
The action potential (AP) in cardiac tissue is important for initiating and coordinating contractions in the heart. In addition, the long refractory period minimizes the potential for developing extrasystoles and arrhythmias. The AP is generated by coordinate changes in different ionic currents. In human (or canine) adult ventricular cells, the depolarization phase of the AP is mainly through the influx of Na+ and Ca2+ through specific voltage gated channels.
A scoping review of outcome measures in ovarian cancer clinical trials
The incorporation of patient-reported outcomes (PROs) is essential for assessing whether a cancer treatment enhances overall patient well-being, beyond merely extending survival. This scoping review aimed to identify and analyze the use of PROs in ovarian cancer clinical trials.
Drosophila male germline stem cells and their transit amplifying daughters depend on G-protein signaling for increasing their mitotic indices in response to mating
In many metazoan tissues, highly specialized cells are constantly lost and need to be replaced by tissue homeostasis from adult stem cells. When adult stem cells divide by mitosis their daughter cells either become new stem cells, or enter a proliferation and differentiation path. Recent studies in Drosophila males showed that germline stem cells (GSCs) can increase their mitotic activity in response to repeated mating.
Significance of BRCA genetic testing for preoperative breast cancer patients
Examining BRCA mutations in preoperative breast cancer patients is very important when selecting a surgical procedure. Although there are advantages and disadvantages associated with knowing about the presence of genetic mutations, including for the patient’s family, there are many benefits for the patient. BRCA genetic testing should be recommended for patients who are strongly suspected of being positive for a BRCA mutation.
Molecular signatures of aggressive pediatric liver cancer
Liver masses account for 5 to 6% of pediatric cancer, which includes hepatoblastoma (HBL) along with rare cases of hepatocellular carcinoma (HCC). The most dangerous form of pediatric liver cancer is aggressive HBL, which can be characterized by chemo-resistance and multiple nodules or metastases at diagnosis, all correlating with worse clinical prognosis. Despite intensive studies and a significant improvement in overall outcomes, very little is known about the key molecular pathways which determine the aggressiveness of pediatric liver cancer.
Research update on the state of the evidence for stem cell and regenerative medicine in cerebral palsy
Stem cell therapy for the treatment of cerebral palsy is a rapidly expanding area of research that has been identified as a high priority by consumers. There are several types and sources of stem cell therapies under investigation. Stem cell treatments proposed for cerebral palsy are believed to provide benefit via some or all of the following mechanisms including immunomodulation, paracrine signaling and supporting endogenous reparative processes.
Deregulation of Slug/Snail2 and TGF-β crosstalk in airway epithelial stem/progenitor cells: A key link between COPD and lung cancer?
This commentary focuses on two recent publications showing deregulation of the transcription factor Slug/Snail2 and TGF-β function in primary bronchial basal/progenitor cells of patients with Chronic Obstructive Pulmonary Disease (COPD) and the impact on proliferation and the expression of genes involved in stem cell maintenance. We discuss the molecular mechanisms related to the exhaustion of airway basal stem/progenitor cells in tobacco smoke-induced COPD, as well as putative links between COPD and lung cancer at the molecular level.
Nemo-like kinase as a potential target for treatment of Diamond Blackfan Anemia
Diamond Blackfan Anemia (DBA) is a congenital bone marrow failure syndrome characterized by hypoproliferative anemia, in which the major defect is ineffective erythropoiesis. Over 70% of patients with DBA have mutations in ribosomal protein subunits, although the precise molecular mechanisms contributing to the pathogenesis of DBA are not well understood.
The significance of triple-capsid-mutant AAV8 for treatment of Sanfilippo Syndrome Type B
Sanfilippo Syndrome Type-B remains an untreatable childhood neurodegenerative disease with great burden for both patient and caregiver. Very few clinical trials have been undertaken to treat the disease, and none of these have yet yielded clinically obtainable products for patients. Caused by a simple enzyme function deficiency, Sanfilippo Syndrome Type-B has been considered a great prospect for gene-therapy interventions.
Mesenchymal Stem Cells and PRP combined therapy promotes gastric leak closure following sleeve gastrectomy
Sleeve gastrectomy is the most common bariatric surgery worldwide. However, such a surgery caries risk of complications associated with morbidity and mortality. Gastric leak can occur and represents one of the most severe complications following sleeve gastrectomy. Since the two last decades, regenerative medicine has emerged, offering new strategies to face to sleeve gastrectomy complications.
Post-allogeneic stem cell transplant FLT3-targeted maintenance therapy: updates and considerations for clinical practice
Acute myeloid leukemia (AML) is characterized by multiple molecular and cytogenetic abnormalities, with increasing data to support clinical and prognostic implications to guide clinical decision making. One of the most well described mutations involves fms-like tyrosine kinase 3 (FLT3) that results in a constitutively active tyrosine kinase and is generally associated with poor prognosis involving shorter overall survival and higher rates of relapse.
Considering Taguchi method as a feature selection method in agent-based models of cancer disease: A mini-review
Cancer biology involves complex dynamics and interactions between cells and the tissue environment. Mathematical modeling and computer simulation can provide a powerful instrument for considering this complexity. Agent-based modeling is a particular discrete hybrid modeling method.
The tumor dose sensitivity matrix and stem cells in head and neck cancer
Radiation therapy (RT) is one of the pillars of locally advanced head and neck cancer (HNSCC) treatment in combination with cisplatin or epidermal growth factor receptor inhibitors. Despite a very high local tumor control rate, approximately 50% of patients with locally advanced disease will develop a recurrence.
Electronic adjuvants to understand and modulate the brain
Different computational models and new devices are under development, aiming to better comprehend and alter brain function. Ternary computating offers new approach by considering a third physiological state of the neuronal membrane: the refractory period (-1), in addition to resting potential state (0) and the action potential.
Parkinson’s disease: cell therapy vs. gene therapy
Parkinson’s disease (PD) is the second most common neurodegenerative disease, manifesting as a characteristic movement disorder with a number of additional non-motor features. The pathological hallmark of PD is the presence of intra-neuronal aggregates of a-synuclein (Lewy bodies). The movement disorder of PD occurs largely due to loss of dopaminergic neurons of the substantia nigra, resulting in striatal dopamine depletion.
The multi-domain protein Piccolo is a versatile scaffolding protein with pleiotropic functions in the brain
The human brain is a complex network of billions of neurons accompanied by astrocytes and microglia among others [1]. Neurons communicate via specialized sites of cell-cell contacts called synapses, where information is transmitted via the presynaptic release of neurotransmitter from synaptic vesicles (SVs) [2]. Through the integration of information transmitted via large networks of neurons, complex tasks, such as learning, memory and various behaviors, are regulated.
Taking BAFF-R targeting CAR T-cells on the road
Chimeric antigen receptor (CAR) T cells were first clinically tested in trials against metastatic solid tumors without therapeutic benefit; however, these efforts established the necessary domains that are required for a functional CAR T-cell. With the characterization of cells within the immune system, the expression of CD19 was found to dictate B cell lineage that remains present on normal and malignant B cells.
Extension: Beliefs about causes of autism and vaccine hesitancy
There are many reasons why people may feel hesitant to accept vaccines for their children, with fears about a link between vaccines and autism spectrum disorder (ASD) being one of the most common. In fact, parents of children with ASD are among those most likely to become vaccine hesitant. Vaccine-hesitant parents may delay and/or refuse one or more vaccines for their children, which subsequently places them at increased risk for contracting and spreading vaccine-preventable diseases.